Nalaganje...

Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin

BACKGROUND AND PURPOSE: In randomized trials, atrial fibrillation (AF) patients receiving dabigatran, a direct oral anticoagulant, had lower risk of intracranial bleeding (ICB) than those on warfarin. However, concerns exist about potential worse outcomes in dabigatran users if bleeding occurs, give...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Alonso, Alvaro, Bengtson, Lindsay, MacLehose, Richard, Lutsey, Pamela L., Chen, Lin Yee, Lakshminarayan, Kamakshi
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116615/
https://ncbi.nlm.nih.gov/pubmed/24994722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.114.006016
Oznake: Označite
Brez oznak, prvi označite!